Highlights the importance of Lp(a) testing in young patients with unexplained or familial CAD despite optimal LDL-C control.
High Lp(a) may contribute to premature and progressive CAD even with optimal LDL-C control, supporting consideration of Lp(a) testing in young patients with unexplained or familial CAD.
Bawahab et al. (Wed,) studied this question.